Bedminster-based Aerie Pharmaceuticals Inc. announced today Vicente Anido Jr., current chairman of Aerie's board, has been named chief executive. He will continue as chairman.
According to the announcement, Anido is an ophthalmology industry veteran, who most recently served as president and CEO of ISTA Pharmaceuticals, prior to its acquisition by Bausch & Lomb last year.
Anido is replacing Aerie's founding chief executive, Dr. Thomas J. van Haarlem, who is stepping down from his positions as president, CEO and director of Aerie. Van Haarlem will serve as a consultant to the company, and also will continue in the role of president of Novaer Holdings Inc., an independent, privately held company possessing ophthalmic delivery technologies previously developed at Aerie.